Crossmark

HER2 Activating Mutations in Estrogen Receptor Positive Breast Cancer

Crossref DOI link: https://doi.org/10.1007/s12609-018-0265-z

Published Online: 2018-04-20

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Murray, Elisa M.

Cherian, Mathew A.

Ma, Cynthia X.

Bose, Ron
License Information

Text and Data Mining valid from 2018-04-20
More Information

Article History

First Online: 20 April 2018

Compliance with Ethical Standards

:

: Cynthia X. Ma has received research support from Puma Biotechnology, Eisai Co. Ltd., Noartis, and Pfizer Inc. Elisa M. Murray and Mathew A. Cherian declare that they have no competing interests. Ron Bose reports grants from Puma Biotechnology, Inc., other from Genentech, other from Foundation Medicine, Inc., during the conduct of the study; other from Novartis, outside the submitted work.

: This article does not contain any studies with human or animal subjects performed by any of the authors.